TR-1: Notification of Major Interest in Shares

RNS Number : 0526H
e-Therapeutics plc
02 June 2017
 

 

For filings with the FSA include the annex


For filings with issuer exclude the annex



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

E Therapeutics Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

Richard Griffiths and controlled undertakings

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

1 June 2017

6. Date on which issuer notified:

2 June 2017

7. Threshold(s) that is/are crossed or
reached:
vi, vii

> 3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect


< 3%

< 3%

54,000,000

54,000,000


20.12%


Ordinary
GB00B2823H99

 


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

54,000,000

20.12%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

Oak Trust Limited

1,500,000

Richard Griffiths

52,500,000

Total

 54,000,000

 

 

The above entities are controlled by Richard Griffiths

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:

James Sutcliffe

15. Contact telephone number:

+44 1534 719761



 

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 


Contact address

(registered office for legal entities)

 


Phone number & email

 


Other useful information

(at least legal representative for legal persons)

 




B: Identity of the notifier, if applicable

Full name

 


Contact address

 


Phone number & email

 


Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)



C: Additional information


For notes on how to complete form TR-1 please see the FCA website.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFSVRDIFIID
UK 100

Latest directors dealings